INS and Insulin resistance: Now the commonly used therapeutic drugs include metformin, insulin sensitizers, thiazolidinediones, etc. However, due to the potential risks of gastrointestinal reaction and adverse cardiac events, the development of safer and more reliable hypoglycemic drugs is still an important research field in the treatment of insulin resistance.